Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,302
datasets available to search
ShareScore release 0.9.0
Dataset results
2,302 results for “B-cells”
Study to Assess the Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell Malignancies
ClinicalTrials.gov study NCT02457559. IPD Sharing: NO. Countries: 2. Publications: 5.
18F-FDG PET Radiomics of Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04317313. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Tazemetostat in Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma With EZH2 Gene Mutation
ClinicalTrials.gov study NCT03456726. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eli
ClinicalTrials.gov study NCT01321541. IPD Sharing: Not stated. Countries: 17. Publications: 2.
T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies
ClinicalTrials.gov study NCT02659943. IPD Sharing: NO. Countries: 1. Publications: 1.
Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT01959698. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma
ClinicalTrials.gov study NCT00670358. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00278408. IPD Sharing: Not stated. Countries: 4. Publications: 1.
A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT02257567. IPD Sharing: Not stated. Countries: 13. Publications: 8.
Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma
ClinicalTrials.gov study NCT02266147. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00802737. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00989586. IPD Sharing: NO. Countries: 1. Publications: 1.
Study to Investigate the Safety and Tolerability of Odronextamab in Patients With CD20+ B-Cell Malignancies
ClinicalTrials.gov study NCT02290951. IPD Sharing: YES. Countries: 5. Publications: 3.
Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00765245. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of ABT-199 Plus Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT03136497. IPD Sharing: NO. Countries: 1. Publications: 45.
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
ClinicalTrials.gov study NCT06533748. IPD Sharing: YES. Countries: 1. Publications: 0.
Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT00867529. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment
ClinicalTrials.gov study NCT04116437. IPD Sharing: YES. Countries: 1. Publications: 2.
Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
ClinicalTrials.gov study NCT02688985. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Safety and Feasibility Study of Combination of State of Art Chemoimmunotherapy, Intensive Central Nervous System Prophylaxis and Scrotal Irradiation to Treat Primary Diffuse Large B-cell Lymphoma of T
ClinicalTrials.gov study NCT00945724. IPD Sharing: Not stated. Countries: 2. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.